Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on…
-
DaVita Inc. 4th Quarter 2022 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. “We continue to have excitement and conviction in our long-term capabilities and…
-
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time….
-
DaVita Emphasized Holistic Care for Kidney Patients and Teammates in 2022
Today, DaVita recognizes the impact its employees, known as teammates, had on kidney care in 2022. Over the last year, DaVita made strides in innovation and clinical excellence while uplifting the…
-
DaVita’s Move It with Purpose Event Raises Funds for Bridge of Life
The event has raised nearly $15 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through its medical missions. DENVER, Dec. 20, 2022 /PRNewswire/ — Today,